Last synced on 10 May 2024 at 11:05 pm

Virtual Reality Behavioral Therapy Device For Pain Relief

Page Type
Product Code
Definition
A virtual reality behavioral therapy device for pain relief is a device intended to provide behavioral therapy for patients with pain. Therapy is administered via a virtual reality display which utilizes a software program containing the behavioral therapy content.
Physical State
Virtual reality display, software
Technical Method
Uses a virtual reality display to provide behavioral based treatment to patients with chronic pain by modifying the patient’s thinking and behavioral patterns
Target Area
Areas of pain
Regulation Medical Specialty
Neurology
Review Panel
Physical Medicine
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
890.5800
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 890.5800 Virtual reality behavioral therapy device for pain relief

§ 890.5800 Virtual reality behavioral therapy device for pain relief.

(a) Identification. A virtual reality behavioral therapy device for pain relief is a device intended to provide behavioral therapy for patients with pain. Therapy is administered via a virtual reality display that utilizes a software program containing the behavioral therapy content.

(b) Classification. Class II (special controls). The special controls for this device are:

(1) Clinical performance testing under the labeled conditions for use must validate the model of behavioral therapy as implemented by the device and evaluate all adverse events.

(2) The patient-contacting components of the device must be demonstrated to be biocompatible.

(3) Software verification, validation, and hazard analysis must be performed.

(4) Electromagnetic compatibility and electrical, mechanical, and thermal safety testing must be performed.

(5) Labeling must include the following:

(i) A warning regarding the risk of nausea and motion sickness;

(ii) A warning regarding the risk of discomfort from the device; and

(iii) A summary of the clinical testing with the device.

[88 FR 985, Jan. 6, 2023]

Virtual Reality Behavioral Therapy Device For Pain Relief

Page Type
Product Code
Definition
A virtual reality behavioral therapy device for pain relief is a device intended to provide behavioral therapy for patients with pain. Therapy is administered via a virtual reality display which utilizes a software program containing the behavioral therapy content.
Physical State
Virtual reality display, software
Technical Method
Uses a virtual reality display to provide behavioral based treatment to patients with chronic pain by modifying the patient’s thinking and behavioral patterns
Target Area
Areas of pain
Regulation Medical Specialty
Neurology
Review Panel
Physical Medicine
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
890.5800
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 890.5800 Virtual reality behavioral therapy device for pain relief

§ 890.5800 Virtual reality behavioral therapy device for pain relief.

(a) Identification. A virtual reality behavioral therapy device for pain relief is a device intended to provide behavioral therapy for patients with pain. Therapy is administered via a virtual reality display that utilizes a software program containing the behavioral therapy content.

(b) Classification. Class II (special controls). The special controls for this device are:

(1) Clinical performance testing under the labeled conditions for use must validate the model of behavioral therapy as implemented by the device and evaluate all adverse events.

(2) The patient-contacting components of the device must be demonstrated to be biocompatible.

(3) Software verification, validation, and hazard analysis must be performed.

(4) Electromagnetic compatibility and electrical, mechanical, and thermal safety testing must be performed.

(5) Labeling must include the following:

(i) A warning regarding the risk of nausea and motion sickness;

(ii) A warning regarding the risk of discomfort from the device; and

(iii) A summary of the clinical testing with the device.

[88 FR 985, Jan. 6, 2023]